Report Content
Chapter 1 Methodology
1.1 Market definitions
1.2 Base estimates and working
1.2.1 North America
1.2.2 Europe
1.2.3 Asia Pacific
1.2.4 Latin America
1.2.5 Middle east & Africa
1.3 Forecast calculations
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Vaccines industry 360° synopsis, 2017 – 2028
2.1.1 Business trends
2.1.2 Age group trends
2.1.3 Disease trends
2.1.4 Technology trends
2.1.5 Regional trends
Chapter 3 Vaccines Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2017 – 2028
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Increasing need for vaccination against coronavirus infection
3.3.1.2 Increasing government funding for vaccine development pertaining to COVID-19 situation
3.3.1.3 Increasing disease prevalence in underdeveloped countries
3.3.1.4 Growing incidence of cancer & HIV in Asia Pacific
3.3.1.5 Increasing vaccines R&D in developed nations
3.3.2 Industry pitfalls and challenges
3.3.2.1 High cost of vaccine storage and transportation
3.3.2.2 Stringent regulations for the approval of vaccines in developed nations
3.3.2.3 Drug-development hurdles
3.4 Growth potential analysis
3.4.1 By age group
3.4.2 By disease
3.4.3 By technology
3.5 COVID-19 impact analysis
3.6 Technology landscape
3.7 Regulatory landscape
3.7.1 U.S.
3.7.2 Europe
3.7.3 Asia Pacific
3.8 Pipeline analysis
3.9 Porter’s analysis
3.10 Competitive landscape, 2021
3.11 PESTEL analysis
Chapter 4 Vaccines Market, By Age Group
4.1 Key segment trends
4.2 Pediatric
4.2.1 Market size, by region, 2017 - 2028 (USD Million)
4.3 Adult
4.3.1 Market size, by region, 2017 - 2028 (USD Million)
Chapter 5 Vaccines Market, By Disease
5.1 Key segment trends
5.2 Cancer
5.2.1 Market size, by region, 2017 - 2028 (USD Million)
5.3 Hepatitis
5.3.1 Market size, by region, 2017 - 2028 (USD Million)
5.4 Pneumococcal disease
5.4.1 Market size, by region, 2017 - 2028 (USD Million)
5.5 DTP
5.5.1 Market size, by region, 2017 - 2028 (USD Million)
5.6 Influenza
5.6.1 Market size, by region, 2017 - 2028 (USD Million)
5.7 Human papilloma virus
5.7.1 Market size, by region, 2017 - 2028 (USD Million)
5.8 Meningococcal disease
5.8.1 Market size, by region, 2017 - 2028 (USD Million)
5.9 Polio
5.9.1 Market size, by region, 2017 - 2028 (USD Million)
5.10 Rotavirus
5.10.1 Market size, by region, 2017 - 2028 (USD Million)
5.11 COVID-19
5.11.1 Market size, by region, 2017 - 2028 (USD Million)
5.12 Others
5.12.1 Market size, by region, 2017 - 2028 (USD Million)
Chapter 6 Vaccines Market, By Technology
6.1 Key segment trends
6.2 Conjugate
6.2.1 Market size, by region, 2017 - 2028 (USD Million)
6.3 Live
6.3.1 Market size, by region, 2017 - 2028 (USD Million)
6.4 Inactivated
6.4.1 Market size, by region, 2017 - 2028 (USD Million)
6.5 Recombinant
6.5.1 Market size, by region, 2017 - 2028 (USD Million)
6.6 Toxoid
6.6.1 Market size, by region, 2017 - 2028 (USD Million)
6.7 Others
6.7.1 Market size, by region, 2017 - 2028 (USD Million)
Chapter 7 Vaccines Market, By Region
7.1 Key regional trends
7.2 North America
7.2.1 Market size by country, 2017 - 2028 (USD Million)
7.2.2 Market size by age group, 2017 - 2028 (USD Million)
7.2.3 Market size by disease, 2017 - 2028 (USD Million)
7.2.4 Market size by technology, 2017 - 2028 (USD Million)
7.2.5 U.S.
7.2.5.1 Market size by age group, 2017 - 2028 (USD Million)
7.2.5.2 Market size by disease, 2017 - 2028 (USD Million)
7.2.5.3 Market size by technology, 2017 - 2028 (USD Million)
7.2.6 Canada
7.2.6.1 Market size by age group, 2017 – 2028 (USD Million)
7.2.6.2 Market size by disease, 2017 - 2028 (USD Million)
7.2.6.3 Market size by technology, 2017 - 2028 (USD Million)
7.3 Europe
7.3.1 Market size by country, 2017 - 2028 (USD Million)
7.3.2 Market size by age group, 2017 - 2028 (USD Million)
7.3.3 Market size by disease, 2017 - 2028 (USD Million)
7.3.4 Market size by technology, 2017 - 2028 (USD Million)
7.3.5 Germany
7.3.5.1 Market size by age group, 2017 - 2028 (USD Million)
7.3.5.2 Market size by disease, 2017 - 2028 (USD Million)
7.3.5.3 Market size by technology, 2017 - 2028 (USD Million)
7.3.6 UK
7.3.6.1 Market size by age group, 2017 - 2028 (USD Million)
7.3.6.2 Market size by disease, 2017 - 2028 (USD Million)
7.3.6.3 Market size by technology, 2017 - 2028 (USD Million)
7.3.7 France
7.3.7.1 Market size by age group, 2017 - 2028 (USD Million)
7.3.7.2 Market size by disease, 2017 - 2028 (USD Million)
7.3.7.3 Market size by technology, 2017 - 2028 (USD Million)
7.3.8 Italy
7.3.8.1 Market size by age group, 2017 - 2028 (USD Million)
7.3.8.2 Market size by disease, 2017 - 2028 (USD Million)
7.3.8.3 Market size by technology, 2017 - 2028 (USD Million)
7.3.9 Spain
7.3.9.1 Market size by age group, 2017 - 2028 (USD Million)
7.3.9.2 Market size by disease, 2017 - 2028 (USD Million)
7.3.9.3 Market size by technology, 2017 - 2028 (USD Million)
7.3.10 Russia
7.3.10.1 Market size by age group, 2017 - 2028 (USD Million)
7.3.10.2 Market size by disease, 2017 - 2028 (USD Million)
7.3.10.3 Market size by technology, 2017 - 2028 (USD Million)
7.4 Asia Pacific
7.4.1 Market size by country, 2017 - 2028 (USD Million)
7.4.2 Market size by age group, 2017 - 2028 (USD Million)
7.4.3 Market size by disease, 2017 - 2028 (USD Million)
7.4.4 Market size by technology, 2017 - 2028 (USD Million)
7.4.5 Japan
7.4.5.1 Market size by age group, 2017 - 2028 (USD Million)
7.4.5.2 Market size by disease, 2017 - 2028 (USD Million)
7.4.5.3 Market size by technology, 2017 - 2028 (USD Million)
7.4.6 China
7.4.6.1 Market size by age group, 2017 - 2028 (USD Million)
7.4.6.2 Market size by disease, 2017 - 2028 (USD Million)
7.4.6.3 Market size by technology, 2017 - 2028 (USD Million)
7.4.7 India
7.4.7.1 Market size by age group, 2017 - 2028 (USD Million)
7.4.7.2 Market size by disease, 2017 - 2028 (USD Million)
7.4.7.3 Market size by technology, 2017 - 2028 (USD Million)
7.4.8 Australia
7.4.8.1 Market size by age group, 2017 - 2028 (USD Million)
7.4.8.2 Market size by disease, 2017 - 2028 (USD Million)
7.4.8.3 Market size by technology, 2017 - 2028 (USD Million)
7.4.9 South Korea
7.4.9.1 Market size by age group, 2017 - 2028 (USD Million)
7.4.9.2 Market size by disease, 2017 - 2028 (USD Million)
7.4.9.3 Market size by technology, 2017 - 2028 (USD Million)
7.5 Latin America
7.5.1 Market size by country, 2017 - 2028 (USD Million)
7.5.2 Market size by age group, 2017 - 2028 (USD Million)
7.5.3 Market size by disease, 2017 - 2028 (USD Million)
7.5.4 Market size by technology, 2017 - 2028 (USD Million)
7.5.5 Brazil
7.5.5.1 Market size by age group, 2017 - 2028 (USD Million)
7.5.5.2 Market size by disease, 2017 - 2028 (USD Million)
7.5.5.3 Market size by technology, 2017 - 2028 (USD Million)
7.5.6 Mexico
7.5.6.1 Market size by age group, 2017 - 2028 (USD Million)
7.5.6.2 Market size by disease, 2017 - 2028 (USD Million)
7.5.6.3 Market size by technology, 2017 - 2028 (USD Million)
7.5.7 Argentina
7.5.7.1 Market size by age group, 2017 - 2028 (USD Million)
7.5.7.2 Market size by disease, 2017 - 2028 (USD Million)
7.5.7.3 Market size by technology, 2017 - 2028 (USD Million)
7.6 Middle East & Africa (MEA)
7.6.1 Market size by country, 2017 - 2028 (USD Million)
7.6.2 Market size by age group, 2017 - 2028 (USD Million)
7.6.3 Market size by disease, 2017 - 2028 (USD Million)
7.6.4 Market size by technology, 2017 - 2028 (USD Million)
7.6.5 South Africa
7.6.5.1 Market size by age group, 2017 - 2028 (USD Million)
7.6.5.2 Market size by disease, 2017 - 2028 (USD Million)
7.6.5.3 Market size by technology, 2017 - 2028 (USD Million)
7.6.6 Saudi Arabia
7.6.6.1 Market size by age group, 2017 - 2028 (USD Million)
7.6.6.2 Market size by disease, 2017 - 2028 (USD Million)
7.6.6.3 Market size by technology, 2017 - 2028 (USD Million)
7.6.7 UAE
7.6.7.1 Market size by age group, 2017 - 2028 (USD Million)
7.6.7.2 Market size by disease, 2017 - 2028 (USD Million)
7.6.7.3 Market size by technology, 2017 - 2028 (USD Million)
7.6.8 Qatar
7.6.8.1 Market size by age group, 2017 - 2028 (USD Million)
7.6.8.2 Market size by disease, 2017 - 2028 (USD Million)
7.6.8.3 Market size by technology, 2017 - 2028 (USD Million)
7.6.9 Egypt
7.6.9.1 Market size by age group, 2017 - 2028 (USD Million)
7.6.9.2 Market size by disease, 2017 - 2028 (USD Million)
7.6.9.3 Market size by technology, 2017 - 2028 (USD Million)
Chapter 8 Company Profiles
8.1 Competitive dashboard, 2021
8.2 Abbott Laboratories
8.2.1 Business overview
8.2.2 Financial data
8.2.3 Product landscape
8.2.4 Strategic outlook
8.2.5 SWOT analysis
8.3 Astellas Pharma, Inc.
8.3.1 Business overview
8.3.2 Financial data
8.3.3 Product landscape
8.3.4 Strategic outlook
8.3.5 SWOT analysis
8.4 AstraZeneca
8.4.1 Business overview
8.4.2 Financial data
8.4.3 Product landscape
8.4.4 Strategic outlook
8.4.5 SWOT analysis
8.5 Serum Institute of India Pvt. Ltd
8.5.1 Business overview
8.5.2 Financial data
8.5.3 Product landscape
8.5.4 Strategic outlook
8.5.5 SWOT analysis
8.6 CSL Limited
8.6.1 Business overview
8.6.2 Financial data
8.6.3 Product landscape
8.6.4 Strategic outlook
8.6.5 SWOT analysis
8.7 Emergent BioSolutions, Inc.
8.7.1 Business overview
8.7.2 Financial data
8.7.3 Product landscape
8.7.4 Strategic outlook
8.7.5 SWOT analysis
8.8 GlaxoSmithKline
8.8.1 Business overview
8.8.2 Financial data
8.8.3 Product landscape
8.8.4 Strategic outlook
8.8.5 SWOT analysis
8.9 Johnson & Johnson
8.9.1 Business overview
8.9.2 Financial data
8.9.3 Product landscape
8.9.4 Strategic outlook
8.9.5 SWOT analysis
8.10 Merck & Co.
8.10.1 Business overview
8.10.2 Financial data
8.10.3 Product landscape
8.10.4 Strategic outlook
8.10.5 SWOT analysis
8.11 Novavax, Inc.
8.11.1 Business overview
8.11.2 Financial data
8.11.3 Product landscape
8.11.4 Strategic outlook
8.11.5 SWOT analysis
8.12 Pfizer
8.12.1 Business overview
8.12.2 Financial data
8.12.3 Product landscape
8.12.4 Strategic outlook
8.12.5 SWOT analysis
8.13 Sanofi Pasteur
8.13.1 Business overview
8.13.2 Financial data
8.13.3 Product landscape
8.13.4 Strategic outlook
8.13.5 SWOT analysis
8.14 Moderna
8.14.1 Business overview
8.14.2 Financial data
8.14.3 Product landscape
8.14.4 Strategic outlook
8.14.5 SWOT analysis
